Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026)

Jazz Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $427.2 million for Q1 2026.

• In Q1 2026, Inventory Average fell 12.2% year-over-year to $427.2 million; the TTM figure through Mar 2026 stood at $427.2 million (down 12.2% YoY), while the FY2025 annual figure was $448.7 million, down 16.71% from the prior year.
• Inventory Average for Q1 2026 stood at $427.2 million, down from $450.1 million in the prior quarter.
• The five-year high for Inventory Average was $1.0 billion in Q1 2022, with the low at $427.2 million in Q1 2026.
• The 5-year median for Inventory Average is $587.2 million (2024), against an average of $624.9 million.
• Peak annual rise in Inventory Average reached 876.04% in 2022, while the deepest fall reached 34.76% in 2022.
• Jazz Pharmaceuticals' Inventory Average stood at $721.1 million in 2022, then decreased by 16.18% to $604.4 million in 2023, then decreased by 15.64% to $509.9 million in 2024, then retreated by 11.73% to $450.1 million in 2025, then slipped by 5.07% to $427.2 million in 2026.
• Business Quant data shows JAZZ's Inventory Average at $427.2 million in Q1 2026, $450.1 million in Q4 2025, and $494.0 million in Q3 2025.